NEXGEL (NXGL) Competitors

LENSAR (NASDAQ:LNSR) and NEXGEL (NASDAQ:NXGL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, community ranking, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.

Does the MarketBeat Community believe in LNSR or NXGL?

LENSAR received 4 more outperform votes than NEXGEL when rated by MarketBeat users. However, 50.00% of users gave NEXGEL an outperform vote while only 38.46% of users gave LENSAR an outperform vote.

Company	Underperform	Outperform
LENSAR	Outperform Votes 5 38.46%	Underperform Votes 8 61.54%
NEXGEL	Outperform Votes 1 50.00%	Underperform Votes 1 50.00%

Does the media refer more to LNSR or NXGL?

In the previous week, NEXGEL had 3 more articles in the media than LENSAR. MarketBeat recorded 4 mentions for NEXGEL and 1 mentions for LENSAR. LENSAR's average media sentiment score of 1.87 beat NEXGEL's score of 0.19 indicating that LENSAR is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LENSAR	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
NEXGEL	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do institutionals & insiders hold more shares of LNSR or NXGL?

40.2% of LENSAR shares are owned by institutional investors. Comparatively, 2.2% of NEXGEL shares are owned by institutional investors. 38.5% of LENSAR shares are owned by insiders. Comparatively, 24.9% of NEXGEL shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has more volatility and risk, LNSR or NXGL?

LENSAR has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500. Comparatively, NEXGEL has a beta of 0.73, meaning that its share price is 27% less volatile than the S&P 500.

Is LNSR or NXGL more profitable?

LENSAR has a net margin of -34.03% compared to NEXGEL's net margin of -52.60%. LENSAR's return on equity of -49.02% beat NEXGEL's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LENSAR	-34.03%	-49.02%	-21.12%
NEXGEL	-52.60%	-71.19%	-34.79%

Which has stronger valuation & earnings, LNSR or NXGL?

NEXGEL has lower revenue, but higher earnings than LENSAR. NEXGEL is trading at a lower price-to-earnings ratio than LENSAR, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LENSAR	$42.16M	2.05	-$14.38M	-$1.46	-5.10
NEXGEL	$4.09M	5.56	-$3.16M	-$0.58	-5.78

Do analysts rate LNSR or NXGL?

LENSAR currently has a consensus price target of $8.00, indicating a potential upside of 7.38%. Given LENSAR's stronger consensus rating and higher probable upside, research analysts plainly believe LENSAR is more favorable than NEXGEL.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LENSAR	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
NEXGEL	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

LENSAR beats NEXGEL on 12 of the 18 factors compared between the two stocks.